Patients with cardiovascular implantable electronic devices (CIEDs), which include pacemakers and implantable cardioverter-defibrillators (ICDs), may request deactivation of their devices as they approach the end of life. The Heart Rhythm Society (2010) has stated that “ethically, and legally, there are no differences between refusing CIED therapy and requesting withdrawal of CIED therapy.” On the basis of the principle that there is no ethical distinction between withholding and withdrawing treatment, this professional organization has suggested that both the antibradycardia and antitachycardia features of these devices may be disabled at the patient's request. We argue that disabling ICD shocks is analogs to a do-not-resuscitate order and is ethically permissible whereas withdrawing pacing from a pacemaker-dependent patient is an act of intentionally hastening death and not morally licit.
Catechism of the Catholic Church. 1997. United States Catholic Conference, Libreria Editrice Vaticana, paragraph 2278.
2.
Congregation for the Doctrine of the Faith. Declaration on Euthanasia, June 1980.
3.
GoldsteinN.E., MehtaD., TeitelbaumE., BradleyE.H., MorrisonR.S.2008. “It's like crossing a bridge” complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. Journal of General Internal Medicine23(Suppl. 1):2–6.
4.
HuddleT., BaileyF.A.2012. Pacemaker deactivation: Withdrawal of support or active ending of life?Theor Med Bioeth33: 421–33.
5.
KapaS., MuellerP.S., HayesD.L., AsirvathamS.J.2010. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: Results of a survey of medical and legal professionals and patients. Mayo Clinic Proceedings85:981–90.
6.
KayG.N., BittnerG.T.2009. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction. Circulation: Arrhythmia and Electrophysiology2:336–9.
7.
KramerD.B., OttenbergA.L., MuellerP.S.2010. Management of cardiac electrical implantable devices in patients nearing the end of life or requesting withdrawal of therapy. Polskie Archiwum Medycyny Wewnetrznej120:497–501.
8.
KramerD.B., OttenbergA.L., GerhardsonS., MuellerL.A., KaufmanS.R., KoenigB.A., MuellerP.S.2011. “Just because we can doesn't mean we should”: Views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators. Journal of Interventional Cardiac Electrophysiology32: 243–52.
9.
LampertR., HayesD.L., AnnasG.J., FarleyM.A., GoldsteinN.E., HamiltonR.M., KayG.N., KramerD.B., MuellerP.S., PadelettiL., PozueloL., SchoenfeldM.H., VardasP.E., WiegandD.L., ZellnerR.2010. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm7:1008–26.
10.
MuellerP.S.2010. Clinicians’ views regarding deactivation of cardiovascular implantable electronic devices in seriously ill patients. Heart Rhythm7:1543–4.
11.
MuellerP.S., OttenbergA.L., HayesD.L., KoenigB.A.2011. “I felt like the angel of death”: Role conflicts and moral distress among allied professionals employed by the US cardiovascular implantable electronic device industry. Journal of Interventional Cardiac Electrophysiology32:253–61.
12.
MuellerP.S., HookC.C., HayesD.L.2003. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clinic Proceedings79:959–63.
13.
MuellerP.S., JenkinsS.M., BramstedtK.A., HayesD.L.2008. Deactivating implanted cardiac devices in terminally ill patients: Practices and attitudes. Pacing Clinical Electrophysiology31:560–8.
14.
PellegrinoE.D.2000. Decisions to withdraw life-sustaining medical treatment: A moral algorithm. JAMA283:1065–7.
15.
SulmasyD.P.1998. Killing and allowing to die: Another look. Journal of Law, Medicine & Ethics26:55–64.
16.
SulmasyD.P.2008. Within you/without you: Biotechnology, ontology, and ethics. Journal of General Internal Medicine23(Suppl 1):69–72.
17.
WilkoffB.L., AuricchioA., BrugadaJ., CowieM., EllenbogenK.A., GillisA.M., HayesD.L., HowlettJ.G., KautznerJ., LoveC.J., MorganJ.M., PrioriS.G., ReynoldsD.W., SchoenfeldM.H., VardasP.E.2008. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): Description of techniques, indications, personnel, frequency, and ethical considerations. Heart Rhythm5:907–25.
18.
ZellnerR.A., AulisioM.P., LewisW.R.2009. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminal illness. Patient autonomy is paramount. Circ Arrhythm Electrophysiol2:340–4.
